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Recurrent flu-like illness with migrating
pulmonary infiltrates of unknown aetiology
P. VAN BLEYENBERGH*, B. NEMERY*, N. NOLARD{ AND M. DEMEDTS
*Pulmonary Division, University Hospital Gasthuisberg, Leuven and {Institute of Public Health, Brussels,
Belgium
Migrating pulmonary infiltrates present a dicult diagnostic and therapeutic challenge. We report on eight patients
(mean age 51 years, range 32–78 years, with a prolonged history of migrating pulmonary infiltrates of unknown
aetiology despite a very elaborate search for infectious causes, hypersensitivity pneumonitis or inhalation fever due
to occupational or domestic exposure to fungi, or to other environmental causes, and for humoral or cellular
immunological incompetence. These patients (one male, seven females) presented with recurrent episodes (mean 6,
range 2–13) of a flu-like illness, often with cough, wheezing and pleuritic chest pain, but without systemic
involvement. Previous medical histories were unremarkable. There was no relation with smoking habits,
occupation, drug use or other possible exposures. Biochemical data were non-specific. There was no peripheral nor
pulmonary eosinophilia; total IgE was normal, with negative RASTs and precipitins to a variety of antigens.
Cultures and serological tests for bacteria, viruses, fungi, etc were non-contributory. Chest X-ray and computed
tomography (CT) scan showed bilateral migratory pulmonary infiltrates, with a predilection for the middle and
lower lung zones, often with a minor-to-moderate pleural effusion. Lung function tests were usually normal; at the
most a slight decrease in diffusing capacity was noted in some patients. There was no or only a slight response to
antimicrobials; systemic corticosteroids were not given. Further evolution was benign with patients being
asymptomatic between the episodes. Despite elaborate investigations, the cause of these ‘pneumonias’ remains
frustratingly unknown.
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‘Recurrent’ pulmonary opacities, i.e. clearing followed by a
return of pulmonary opacities in the same lung zones, are
well recognized in certain diseases: for example, chronic
eosinophilic pneumonia, partially treated bacterial pneu-
monia and endobronchial obstructions impairing airway
clearance.
There are, however, only few diseases in which fleeting or
migratory pulmonary infiltrates are common, and often
they present a dicult diagnostic and therapeutic challenge.
This is seen in syndromes associated with peripheral and/or
pulmonary eosinophilia (simple pulmonary eosinophilia or
Loer’s syndrome, hypersensitivity to drugs, parasitic
infections or fungus-induced), and in Wegener and
Churg-Strauss vasculitis. Fleeting infiltrates have also been
noted in several case series of idiopathic bronchiolitis
obliterans with organizing pneumonia (BOOP). Never-Received: 27 September 2000 and accepted in revised form: 26
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0954-6111/01/050348+09 $35?00/0theless, it can be very dicult to make a definite diagnosis
because sometimes all tests remain inconclusive despite very
extensive investigations.
We report on eight selected patients (mean age 51 years,
range 32–78 years) with a history of migrating pulmonary
infiltrates. In these cases a definite diagnosis could not be
made despite elaborate search for a specific cause, especially
for infections, for immunological or toxic reactions to
environmental agents, and for collagen vascular diseases.
We followed most of them over a period of several years
and they all had a benign evolution and were asymptomatic
between the episodes.
Review of cases
We retrospectively reviewed the records of all patients with
flu-like illness and recurring infiltrates presenting at our
outpatient clinic over a period of 6 years. In most of them a
definite diagnosis could be made, which mostly was diffuse
interstitial lung disease (especially idiopathic interstitial
pneumonia or associated with collagen vascular disease),
infection, hypersensitivity pneumonitis or another form of
inhalation pathology or drug reaction, and sometimes# 2001 HARCOURT PUBLISHERS LTD
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chest wall irradiation for breast tumour).
In eight patients, i.e. about one-fifth of these cases with
flu-like illness and recurring infiltrates, no final diagnosis
could be made. In general, each of the insults in these eight
patients were less debilitating than those which had led to a
specific diagnosis and especially no residual abnormalities
could be retained. These eight ‘idiopathic’ forms of flu-like
illness and recurring infiltrates are briefly described in the
following paragraphs.FIG. 2. CT-scan of case 1 shows patchy consolidations in both
FIG. 1. Chest X-ray of case 1 shows bilateral
reticulomicronodular infiltrates in the lower lung zones.CASE 1
A 59-year-old housewife experienced three acute episodes
of a flu-like illness, with high fever (38?58C), wheezing and
pleuritic chest pain. Radiological examination showed
bilateral reticulomicronodular infiltrates on chest X-ray,
most often in the lower lung zones (Fig. 1) and patchy
consolidation in the posterior lung zones on CT scan
(Fig. 2). The total amount of cells in the bronchoalveolar
lavage (BAL) fluid was slightly increased (372?093ml71),
with a predominance of neutrophils (37%) and lympho-
cytes (48?5%), and a CD4/CD8 ratio of 2?44. The diffusing
capacity was slightly decreased during acute exacerbations
(77% predicted).
Environmental, mainly mycological, investigations by
the Institute of Public Health revealed no specific findings.
CASE 2
A 43-year-old housewife reported at least four acute
episodes of a flu-like illness, with high fever (38?58C),
dyspnoea, wheezing and pleuritic chest pain, over the last 2
years. We noted bilateral infiltrates in the middle and lower
lung zones, with a moderate pleural effusion. The total
amount of cells in BAL fluid was slightly increased
(311?429ml71), with a predominance of macrophages
(93%). Lung function tests were normal. There was a mild
hypoxaemia (PO2: 69 mmHg) with an increased A–aO2
gradient (38?9mmHg), during one acute episode.
CASE 3
A 78-year-old housewife experienced two acute episodes of
a flu-like illness, with anorexia and weight loss, generalposterior lung zones.
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cough) were of minor importance. Bilateral migrating
infiltrates were noted in the middle and lower lung zones
with a BOOP-like consolidation in the left dorsobasal
segments, and a moderate pleural effusion. There was a
mild decrease in diffusing capacity (74% predicted) during
acute episodes. Arterial blood gases revealed a mild
hypoxaemia (PO2: 72mmHg) with a discrete increase of
the A–aO2 gradient (26?6mmHg).
CASE 4
A 54-year-old housewife experienced six acute episodes of a
flu-like illness, with low-grade fever (37?58C), fatigue and
sometimes also pleuritic chest pain. Again, respiratory
symptoms were of minor importance. Pulmonary X-ray
and CT scan showed bilateral migrating infiltrates,
especially in the middle and lower lung zones, with a
moderate pleural effusion. Lung function tests were normal.
Environmental studies by the Institute of Public Health
revealed no specific abnormalities.
CASE 5
A 32-year-old female dentist reported 13 acute episodes of a
flu-like illness, with high fever (38.58C), dyspnoea, wheezing
and pleuritic chest pain. There were bilateral migrating
patchy infiltrates in the middle and lower lung zones
(Fig. 3), sometimes with a discrete pleural effusion. BAL
fluid examination showed a normal amount of cells, with a
normal differentiation. Lung function tests were also
normal.
There was no correlation with professional activities;
radio-allergo sorbant tests (RASTs) on isocyanates were all
negative. Environmental studies by the Institute of Public
Health revealed the presence of different fungi in several
rooms of the house. However, serological tests remainedFIG. 3. CT-scan of case 5 shows bilateral patchy infiltrates.negative and we could not demonstrate a lymphocytic
alveolitis. Furthermore, the last episodes occurred after she
had moved to another house.
CASE 6
A 65-year-old female, a former administrative worker,
experienced three episodes of a flu-like illness, with fever
(388C), fatigue and only minor respiratory symptoms.
There were again bilateral migrating infiltrates in the
middle and lower lung zones (Fig. 4). BAL evaluation
showed a marked increase of the total amount of cells
(539?189ml71), with a lymphocytic predominance (49%)
and an eosinophilia of 6?5. The CD4/CD8 ratio was 0?5.
The eosinophil count in the peripheral blood was not
elevated (0%). Lung function tests were normal. There was
no hypoxaemia and the A–aO2 gradient was not increased.
Thoracoscopic lung biopsies revealed an infiltration with
mononuclear cells, mostly lymphocytic, and one small
epithelioid granuloma.
Environmental studies by the Institute of Public Health
revealed no specific findings.
CASE 7
A 36-year-old female dentist experienced 12 acute episodes
of a flu-like illness, with fever (388C), a dry cough and
pleuritic chest pain. Radiological evaluation revealed rather
diffuse migrating infiltrates, with moderate pleural effusion.
BAL evaluation showed a normal amount of cells, with a
normal differentiation. Lung function tests were normal.
There was no correlation with professional activities.
Environmental studies by the Institute of Public Health
revealed no specific findings.
CASE 8
A 40-year-old sports teacher experienced nine episodes of a
flu-like illness, with fever, mild dyspnoea and pleuritic chest
pain. Pulmonary X-ray and CT scan showed migrating
infiltrates, mostly in the middle or lower lung zones at the
left (Fig. 5) or at the right. BAL evaluation showed a
normal amount of cells, with a normal differentiation. Lung
function tests were normal.
Environmental studies by the Institute of Public Health
revealed no specific findings.
Results
PATIENT CHARACTERISTICS
We studied eight selected patients, one male and seven
females, with a mean age of 51 years (range 32–78 years)
(Table 1). They all presented with repeated flu-like illnesses
which included fever in all but one, sometimes also
shortness of breath, cough with occasional production
of purulent sputum, often wheezing (cases 1, 2 and 5)
and pleuritic chest pain (cases 1, 2, 4, 5, 7 and 8).
FIG. 4. CT-scan of case 6 shows bilateral consolidations.
FIG. 5. CT-scan of case 8 shows a consolidation in the left lateral lung zone.
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fatigue, anorexia and minimal weight loss. Crackles were
not noted.
Previous medical histories were unremarkable. There was
no relation with smoking habits, occupation, hobbies or
contact with pets, including birds.There was no history or evidence of exposure to
medications, risk factors for human immunodeficiency
virus infection, or recent travel. In two dentists (cases 5
and 7) there was a professional exposure to chemicals
including isocyanates, but the flu-like symptoms also
occured outside the working environment in both cases.
TABLE 1. Patient characteristics
Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 Patient 7 Patient 8
Sex Female Female Female Female Female Female Female Male
Age at diagnosis 59 43 78 54 32 65 36 40
Exposure None None None None Dentist
Fungi in house
None Dentist None











24 36 12 48 60 12 60 72
Number of
exacerbations
3 4 2 6 13 3 12 9
TABLE 2. Laboratory data (during acute exacerbations)
Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 Patient 7 Patient 8
CRP (g dl71) ND 3?5 4?6 ND 9?5 0?9 2?1 ND
Eosinophilia (cells ml71) 0 210 283 100 0 0 ND 120
IgE (IU/dl71) 35?7 18?6 23?4 5?6 2?9 11?4 39?2 55?1
Routine urine analysis ND Negative Negative ND ND Negative Negative Negative
Auto-antibodies Negative Negative Negative Negative Negative Negative Anticytoplasma  Negative
Immune complexes Negative Negative Negative Negative Negative Negative Negative Negative
Precipitins (fungi, etc.) Negative Negative Negative Negative Negative Negative Negative Negative
(A–a)O2 gradient (mmHg) ND 38?9 26?6 ND ND 3?1 12?7 11
Cellular/humoral immunity normal normal normal normal normal normal normal normal
ND=not done.
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Laboratory data were non-specific (Table 2): inflammatory
parameters were not raised, there was no eosinophilia in the
peripheral blood, total IgE was normal, with negative
RASTs on occupational allergens, house mite, pollen and
fungi, and negative precipitins for fungi and avian proteins.
Mild hypoxaemia was present in two of five patients in
whom arterial blood gases were measured. The alveolar–
arterial oxygen gradient was normal, except in these two
patients with mild hypoxaemia, in whom it was slightly
elevated.
We could not demonstrate any abnormality in the
cellular or humoral immune response.
MICROBIOLOGY
In all patients at least two blood cultures had been obtained
before a possible antibiotic therapy was started. If
available, sputum was collected and in six patients BAL
was performed. Blood, sputum and lung aspirates were sent
for conventional cultures as well as for selective culture for
mycobacteria (Lo¨wenstein-Jensen). Gram-, Ziehl–Neelsen
and silver stain was obtained from every sample. Antigendetection tests and specific cultures for respiratory
viruses (adenovirus, herpes virus, RSV, influenza virus,
para-influenza virus) were performed on BAL fluid, as well
as silver stain and immunofluorescence testing for P. carinii,
and direct fluorescent antibody (DFA) test for detection
of Legionella antigen. Acute and convalescent sera were
tested by immunofluorescence for IgG antibodies to
Mycobacterium pneumoniae and by microimmunofluores-
cence for IgG antibodies to Chlamydia pneumoniae.
Polymerase chain reaction (PCR) techniques were not used.
All these microbiological tests were non-contributory
(Table 3).
RADIOLOGY
Chest radiograph and CT scan were performed in all eight
patients. They both showed migratory infiltrates possibly in
both lungs, with a predilection for the middle and lower
lung zones. In five patients (62%), a moderate pleural
effusion was noted.
Sinus X-ray or CT scan was performed in seven patients
and never showed any inflammatory changes or other
abnormalities.
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Lung function, including volumes [vital capacity (VC),
forced expiratory volume in 1 sec (FEV1), total lung
capacity (TLC)] and diffusing capacity (DLCO), was
measured according to the guidelines of the European
Respiratory Society (ERS) (1,2), and expressed in percen-
tage of the predicted values proposed by the ERS (2).
The results of these tests were mostly normal (Table 4).
In two patients, a slight decrease in the diffusing capacity
was noted during an acute phase of their pulmonary
disease, although not consistently during each exacerba-
tion. After the acute episode, the diffusing capacity always
returned to normal values.
BRONCHOALVEOLAR LAVAGE
Lavage with 4650ml saline was performed in six patients.
Immunological evaluation of the BAL fluid showedTABLE 3. Microbiology
Cultures (bacteria, fungi, mycobacteria, viruses)
Serology
Tuberculin skin test
TABLE 4. Lung function tests (during acute exacerbations)
Patient 1 Patient 2 Patient 3
FEV1 (% predicted) 85 95 90
TLC (% predicted) 114 129 89
DLCO/KCO (% predicted) 77/66 81/77 74/101
TABLE 5. Bronchoalveolar lavage
Cells (millions)






D4/CD8 ratiovariable results (Table 5): the total amount of cells was
raised in only two patients, with most often a predominance
of macrophages. In two patients (cases 1 and 6) we noted a
preponderance of lymphocytes (49%) with a decreased
CD4/CD8 ratio (0?5%) and some eosinophilia (6?5%) in
one of these two patients.
Neither microbiological agents nor other foreign sub-
stances were found. Neither could we demonstrate any sign
of malignancy.
HISTOLOGY
Transbronchial biopsies were performed in five patients
(cases 1, 3, 6, 7 and 8) and never showed any specific
abnormality. One patient (case 6) underwent a video-
assisted thoracoscopy, during which several lung biopsies
were taken. These revealed an infiltration with mono-
nuclear cells, mostly lymphocytic, and one small non-







Patient 4 Patient 5 Patient 6 Patient 7 Patient 8
91 105 108 84 101
111 98 93 104 107
85/90 87/91 89/93 87/81 110/113
Mean Range Normal values (29)
Non-smokers Smokers
16.9 9.8–39.9 15–20 60–120
89 35–150
255 67–539 100–150 400–800
65 14.5–93 85–93 90–93
9 2–37 0–2 1–4
1 0–6.5 51 51
25 5.5–49 7–12 3–6
1 0.5–2.44 1.5–2.0 1.0–1.5
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Treatment consisted mostly of antibiotics, broncho-
dilating drugs and anti-pyretics; systemic corticosteroids
were not given. There was little to no immediate response
to medication and most often, spontaneous regression
of symptoms and radiological signs occurred within 2
weeks.
Further evolution was benign, with all patients being
asymptomatic between episodes. The mean follow-up
period was 40 months (range 12–72 months), during which
several exacerbations were noted (mean 6, range 2–13).
Discussion
We report on eight patients with a history of recurrent
flu-like illness and migrating pulmonary infiltrates. In all
cases, investigations were non-contributory and despite an
elaborate search, the cause of these infiltrates remained
unknown. Spontaneous recovery always occurred within 10
days to 2 weeks, with complete resolution of the
radiological abnormalities in most cases. Further evolution
was benign, with all patients being asymptomatic between
episodes.
The differential diagnosis of recurrent migrating infil-
trates is broad and includes especially infectious causes,
hypersensitivity pneumonitis due to occupational or do-
mestic exposure to fungi or to other environmental causes,
acute and chronic eosinophilic pneumonia, BOOP, drug-
induced lung disease, neoplastic disorders and even
pulmonary vasculitis.
All these potential causes will now be considered but, as
further evidence will show, all these disease entities were
ruled out with reasonable confidence.
Pulmonary infection can have an acute, subacute or
insidious onset, with fever and chills, a cough with purulent
sputa and dyspnoea. The infection can be exogenous or
may reflect a reactivation of latent endogenous pathogens.
A number of pulmonary roentgenographic patterns can be
seen, either alone or in combination.
Known specific infectious causes of our patients’
recurrent pulmonary disease are unlikely because routine
and special stains did not demonstrate a predominant
pathogen, serological tests remained negative, immune
depression was not present and there was no beneficial
effect of antibiotic therapy. Indeed, although antibiotics
were often prescribed during the first period of febrile
illness, they were withheld in most of the following episodes
and we always noted a benign evolution with a fast and
total regression of all symptoms.
Hypersensitivity pneumonitis (HP) is an immunologi-
cally-mediated inflammation of the lungs caused by
repeated inhalation of organic dusts or other agents by a
susceptible host (3,4). A diagnosis of acute presentations of
HP was considered in several patients (e.g. cases 1 and 6
with high lymphocytosis on BAL) but this could not be
confirmed, both on the grounds of the clinical history
(recurrence after avoidance of suspected agent) and absenceof supportive data (no serological signs of hypersensitivity
reaction).
Allergic bronchopulmonary aspergillosis or other fungal
disease (5–7) was excluded because the patients in whom
this was considered had no history of atopy nor bronchial
asthma, because there were no signs of hypersensitivity nor
eosinophilia and because the presence of fungi could not be
demonstrated.
In patients with diffuse air-space disease, acute or chronic
eosinophilic pneumonia must be considered in the differ-
ential diagnosis. In our series we noted a slight elevation of
eosinophils (6?5%) in one patient with a lymphocytic
predominance on BAL (case 6). Lung biopsies, taken
during video-assisted thoracoscopy only revealed an
infiltration with mononuclear cells, mostly lymphocytes,
and one small non-specific epithelioid granuloma. The
absence of eosinophilia, both pulmonary and peripheral,
and the exclusion of known causes, allows us to reject the
diagnosis of eosinophilic pneumonia in our patients (8–11).
BOOP presents with cough, fever, dyspnoea, malaise,
bibasilar crackles, and bilateral, non-lobar, patchy alveolar
and interstitial infiltrates (12–14). In most cases, the
disorder is idiopathic, but it can develop after a viral
illness, mycoplasma infection, inhalation of irritant fumes,
high-dose chemotherapy or radiotherapy, or a variety of
other diseases. In most cases CT scan reveals areas of
consolidation that are frequently peripheral and may be tri-
angular, with the base of the triangle at the pleural surface,
and which do not tend to disappear spontaneously (15).
Infiltrates can, however, be migratory, especially in the
idiopathic form of BOOP (13,16,17). BAL reveals foamy
macrophages, a predominance of lymphocytes or a rather
colourful pattern with elevation of lymphocytes, but also of
neutrophils and eosinophils, and a decreased CD4/CD8
ratio. A restrictive lung function pattern with a decrease in
the carbon monoxide diffusing capacity can be observed in
most cases (13).
Although there are some similarities between the findings
in our patients and those in BOOP, the very mild clinical
picture despite extensive radiological lesions, the absence of
any sign of inflammation, the normal physiological findings
and the spontaneous recovery after each acute exacerbation,
argue strongly against a diagnosis of idiopathic BOOP.
Recurrent lipoid pneumonia deserves consideration in
the diagnostic setting of diffuse air-space disease that
occupies the inferoposterior portions of the lung. Aspira-
tion while using mineral oil or oily nose drops is the usual
cause. The clinical and roentgenographic findings vary from
an asymptomatic pulmonary mass or infiltrate to features
resembling infection (18). BAL typically reveals lipid-laden
macrophages (19).
Inour series, nopatientmentioned the use of oily products.
Furthermore, the extent of the lung disease and the absence
of specific BAL fluid findings, rule against this diagnosis.
Certain neoplasms can result in diffuse air-space disease
and there have been reports of pulmonary lymphoproli-
ferative disorders that give rise to recurrent infiltrates as
early as 5 years before the definite diagnosis is made
(20–23). However, lung involvement without thoracic
lymph-node involvement is extremely rare (22). No patient
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system involvement. Further follow-up showed a benign
evolution in all our patients.
The only connective tissue or vasculitic disorder that
perhaps merits discussion in these cases is Wegener’s
granulomatosis. In the limited from of the disease,
glomerulonephritis and destruction of the upper respiratory
tract are absent (24,25). In this instance the disease may be
clinically subacute as in our patients. However, in the case of
limited Wegener’s granulomatosis, one would expect to find
raised inflammatory parameters, a positive test for anti-
neutrophil cytoplasmatic antibodies (ANCA) and a history
of haemoptysis, all of which were absent in our patients.
In any febrile or afebrile patient with unexplained chest
radiographic abnormalities, the possibility that the ob-
served abnormalities are drug-induced must be kept in
mind. The physician’s alertness to possible drug toxicity, a
meticulous drug history and the evolution of disease after
withdrawal of the drug, are most important in making a
correct diagnosis. The clinical manifestations of drug-
induced lung disease are protean and the radiographic
manifestations are entirely non-specific. BAL fluid shows
either an eosinophilic or lymphocytic predominance
(26–28). None of our patients were taking known pneumo-
toxic drugs at the time of diagnosis. During their ensuing
follow-up period, most of the medication was stopped, but
recurrences of the flu-like disease with pulmonary infiltrates
were still noted.
We also have no arguments for inhalation fever nor for
toxic or chemical pneumonitis since we never could
document any history of high exposure to organic or
anorganic environmental agents, and in the few suspected
cases, symptoms persisted after stopping any possible work-
or hobby-related exposure or even moving house.
The eight patients of the present study, presenting with a
recurrent flu-like illness and migrating pulmonary infil-
trates, do not fit well into any of the above-mentioned
diseases. Despite an elaborate search, we could not find any
evidence for infection, humoral or cellular immunological
incompetence, hypersensitivity pneumonitis or eosinophilic
pneumonia. Although there are some similarities with the
findings in idiopathic BOOP, several disease features weigh
against this diagnosis.
We admit that in some patients investigations could have
been incomplete. However, taking into account the minimal
affect of the disease on the patients’ general condition and
the self-limiting nature of these disorders, we believe that all
the necessary tests of ‘good clinical practice’ were
performed.
In conclusion, the cause of these pneumonias remains
frustratingly unknown and we are left with a describing
definition of a ‘syndrome of idiopathic migrating pulmon-
ary infiltrates’.
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